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Abstract 
This study aimed at systematically reviewing the Gynecological Morbidity among women in the reproductive 
age by summarizing the prevalence of gynecological morbidity among reproductive age women is provided to 
develop research priorities. This systematic review was conducted based on PRISMA guidelines. The authors 
searched all published articles on the prevalence of gynecological morbidity. Electronic data bases such as 
PubMed were searched to identify observational studies on the subject. The study concluded that the polled 
prevalence of overall gynecological morbidity was high. This pooled prevalence enabled us to conclude that the 
effect of gynecological morbidities is high to hamper the productivity of reproductive age women in the world 
particularly in a developing nations. 
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1.1 Introduction 
A healthy reproductive life is an essential component of the general health and well-being of a woman. 
Reproductive health problems constitute the leading cause of ill health in women of reproductive age group 
worldwide especially to those in developing countries. It accounts for 21.9% of the disability-adjusted life years 
lost by women aged 15–45 years (Abouzahr & Vaughan, 2000). 
The universal access to reproductive health was identified as a developmental goal in the 1994 International 
conference for population and  
Development (ICPD) (WHO/UNFPA report, 2016).  
After ICPD the  major thrust was given in reducing total fertility rate and maternal mortality rate and improving 
the health of the women. The health of women is also affected by problems that are not related to pregnancy or 
child birth (see table 1). Hence giving focus more on mortality indicators may ignore many treatable 
gynecological conditions that cause significant distress in women’s lives (Abraham, Varghese, Satheesh, 
Vijayakumar, Gopakumar & Mendez, 2014). 
Table (1): Risk of dying from pregnancy 
Region Risk of Dying 
Africa 1 in 16 
Asia 1in 65 
Latin America and Caribbean 1 in 130 
Europe 1 in 1,400 
North America 1 in 3,700 
All Developing Countries 1 in 48 
All Developed Countries 1 in 1,800 
Obstetrics, Gynecological, and Contraceptive morbidities are the three broad categories of reproductive 
morbidities. Gynecological morbidity is structural and functional disorder of the reproductive tract (genital tract). 
Gynecological morbidity is not related to pregnancy, delivery and puerperium, it may be related to sexual 
behavior (Jejeebhoy, Koenig & Elias, 2003). 
Reproductive health problems are leading cause of women’s ill health & death worldwide which constitutes 
about one third of total disease burden among women of reproductive age groups in developing countries.4 It 
result in 250 million years of reproductive life loss each year worldwide and reduce the overall productivity of 
women by as much as 20 %  (Vibha, Verma & Doshi, 2012).  
Addressing gynecological morbidity is a complex process as women either don’t consider it a significant 
health problem or hesitate to talk on it & other determinants like illiteracy, ignorance, gender discrimination & 
poor social status, lack of decision making power especially in women from socially and economically backward 
areas, further complicates the problem and reduces reporting of cases and delayed treatment which ultimately 
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increases the prevalence (Gaash, Kausar & Bashir, 2005). 
World Health Organization (WHO) estimates that 300 million women in developing countries suffer from 
short and long-term illnesses due to pregnancy and childbirth-related complications. Childbirth is the time of 
greatest lifetime risk of mortality for the mother and her baby (WHO, 2013). 
Maternal mortality due to direct and indirect obstetric causes is one of the main factors which results in low 
life expectancy for women. Most of the maternal deaths occur within 24 hours of childbirth, followed by during 
pregnancy, within seven days of delivery and from two to six weeks after childbirth each accounting for 50%, 
25%, 20% and 5% of maternal mortality respectively (Garg, Chhabra & Zothanzami, 2006). 
Gynecological morbidities have negative impact on women health related quality of life, in terms of marital 
disharmony excluding them from social and religious life. The untreated conditions can cause pregnancy related 
complications, congenital infections, and chronic pain which significantly increase the risk of acquiring Pelvic 
,inflammatory Disease and HIV.  
Gynecological disorders have a substantial impact on female reproductive ability, and mental health ability 
which perform routine physical activities (Kaur, Jairus & Samuel, 2013). 
 
1.2 Problem Statement 
Relying on evidence derived from research into the issues surrounding women’s health and gender, this study 
uses a rights-based approach founded particularly on the international law regimes to argue for a nationally led, 
coordinated approach to women’s sexual and reproductive health, and recommends actions within seven key 
areas. The action areas are:  
1. Promoting positive and respectful attitudes to sex and sexuality.  
2. Developing women’s health literacy.  
3. Increasing reproductive choice.  
4. Facilitating women’s health throughout pregnancy and birth.  
5. Expanding prevention and treatment of reproductive cancers and menstrual issues.  
6. Improving prevention and treatment of sexually transmissible infections (STIs).  
7. Equipping the health workforce to better respond to women’s health needs. 
There are no global wide studies on the magnitude of gynecological morbidities that can be used for policy 
advocacy. Therefore, the problem of this study stems out of its attempt to be summarizing the prevalence of 
gynecological morbidity among reproductive age women is provided to develop research priorities. The authors 
performed a systematic review and meta-analysis on studies conducted on gynecological morbidities which 
aimed at exploring the prevalence of gynecological morbidities among reproductive age women in the world. 
 
1.3 Methods and producers 
This systematic review was conducted based on PRISMA guidelines (see figure 1). The authors searched all 
published articles on the prevalence of gynecological morbidity. Electronic data bases such as PubMed were 
searched to identify observational studies on the subject (Moher, Liberati, Tetzlaff & Altman, 2009). 
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Figure (1): PRISMA guidelines 
Papers were also identified by searching references from all included studies. No date restriction was 
applied in the search. The authors first screened the title, and abstracts. Then reviewed the full-text of the eligible 
articles. 
The authors included all epidemiologic studies which reported the prevalence of gynecological morbidity 
among 15-49 years old women all over the world. Only studies which used random sampling or census data to 
find participants were included. 
All source studies were original cross-sectional study or a baseline survey of longitudinal study which is 
written in English and contained the minimum information necessary to calculate pooled analysis of prevalence 
(number of the subjects and number of gynecological morbidity events).  
Studies were included if they explicitly defined gynecological morbidity which in turn may include at least 
one types of gynecological morbidity (i.e. Reproductive tract infection, menstrual dysfunction, pelvic organ 
prolapse and infertility). The authors excluded studies if the participants were not in the age range of 15-49, 
pregnant women, if the study reported only the overall prevalence of gynecological morbidity without 
mentioning the morbidity types. The authors also excluded studies not only with qualitative study but also 
studies that utilized non-random sampling. 
 
1.4 Data extraction 
The standardized data abstraction form was designed to capture and code all relevant studies level information 
required for analysis. Authors selected the studies and extracted the data. For all included studies, we recorded 
the following information: 
• Author 
• Year of publication 
• Countries 
• Sampling method 
• Data collection method 
• Number of subjects 
• Number of people with gynecological morbidity 
 
1.5 Quality assessment of included studies 
The authors used the Joanna Briggs Institute (JBI) Prevalence Critical Appraisal Tool to assess quality of 
individual paper as show in table 2. 
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Table (2): Quality assessment of the 18 paper used for the meta-analysis [Y= yes, N=No, U=unclear]. 
S. No Author (year) 
JBI Quality Items 
1 2 3 4 5 6 7 8 9 10 Score 
1 Abraham A et al. (2014) Y Y Y Y Y Y Y Y Y Y 10 
2 Verma A et al.(2015) Y Y Y Y Y N U Y Y N 7 
3 Fahimeh et al.(2011) Y Y Y Y Y Y Y Y Y Y 10 
4 Filippi V et al. (1997) Y Y Y N Y Y Y Y Y Y 9 
5 Inamdar IF et al. (2013) Y Y Y Y Y Y N Y Y Y 9 
6 Masterson A et al.(2014) Y Y Y Y Y U U Y Y Y 8 
7 Gokler M et al. (2014) Y Y Y Y N Y Y Y Y Y 9 
8 Miteshkumar N (2010) Y Y Y Y Y Y Y Y Y Y 10 
9 Bhatnagar N et al. (2013) Y Y Y Y Y U U Y Y Y 8 
10 Philippov O et al. (1998) Y Y Y Y N Y Y U N N 6 
11 Chellan R (2004) N N N N N N N N N N 10 
12 Riyami et al. (2004) Y Y Y Y Y Y Y Y Y Y 10 
13 GargS et al. (2002) U Y U Y Y Y U Y N N 5 
14 Poornima S et al. (2013) Y Y Y Y Y Y Y N N Y 8 
15 Kaur S et al. (2013) Y N U N Y Y Y Y Y Y 7 
16 Kumari S et al. (2000) Y U U N Y Y Y Y Y N 6 
17 Siae M et al. (2002) Y Y Y Y Y Y Y Y Y Y 10 
18 Gosalia VV et al. (2012) Y Y Y Y Y N N N N N 5 
 
1.6 Statistical analysis 
To include proportion close to 0 and 1, we enabled the Freeman- Tukey double arcsine transformation option 
(ftt); otherwise, studies with estimated proportion at 1 and 0 would be excluded from the analysis leading to a 
biased pooled estimate. The transformed prevalence is weighted very slightly towards 50% and, thus, studies 
with prevalence of 0 can be included in the analysis. 
Meta-analyses were conducted using the metaprop command for prevalence and metainf for influence of 
single study. Meta-analyses were conducted summarizing the prevalence of gynecological morbidity among 
women of reproductive age. First, the prevalence of each type of gynecological morbidity (pelvic organ prolapse, 
infertility, reproductive tract infection and menstrual disorder) was analyzed separately. 
Then overall gynecological morbidity prevalence was assessed by stratifying by types of gynecological 
morbidities. According to the expected heterogeneity across studies, a random-effects model was used to 
calculate pooled prevalence. In all cases 95% confidence intervals were calculated using the binomial exact 
method to calculate. Statistical heterogeneity was evaluated with the Cochran chi-square (χ2) and quantified with 
the I2 statistic (low is 25%, moderate 25-50%, high 50%). 
Publication bias was evaluated by testing for funnel plot asymmetry, Begg’s rank correlation test and 
Egger’s linear regression test. Significance was set at a P value of less than 0.05. Sensitivity analyses include 
investigation of the influence of a single study on the combined association by omitting one study in the pooled 
analysis. All statistical calculations were made using the Stata Statistical Software Package, Version 12.0. 
Ancillary analyses were performed using comprehensive meta-analysis software. 
 
1.7 Overall gynecological morbidity prevalence 
Overall gynecological morbidity prevalence was assessed all types of gynecological morbidities by stratifying. 
Pelvic organ prolapse with 11 studies, infertility with 8 studies, reproductive tract infection with 15 studies, 
menstrual disorder with 11 studies, totally 44(some individual studies have more than one outcome variable) 
studies with 48,634 study population were included in the overall pooled summary of meta-analysis prevalence. 
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The point prevalence of gynecological morbidity with 44 individual study populations ranges from 0% (in pelvic 
organ prolapse) to 70% (in reproductive tract infection). 
The overall pooled random effect meta-analysis prevalence of gynecological morbidity was 22% (95% 
CI=17%-27%, I2=99.38%, p=000). 
 
1.8 Discussion 
This is a comprehensive report attempting to sensitize the prevalence estimation of gynecological morbidity 
among reproductive age women by using meta-analysis. This comprehensive systematic review with meta-
analysis of observational studies conducted in the world included 18 reports and 31,808 women population. 
Thus, it was possible to provide a reliable estimate of prevalence. 
Our comprehensive systematic review and meta-analysis found that 10% of women have had pelvic organ 
prolapse, 7% of them were infertile; reproductive tract infection is the most 37% followed by menstrual disorder 
28%. The pooled random model meta-analysis of overall gynecological morbidity is 22% (95% CI=17%-27%). 
The average number of complaints of gynecological morbidity ranges from (1.2-1.5); different types of 
gynecological morbidities may appear concurrently on individual women. The existence of some types may 
favor condition for the occurrence of the other (Inamdar, Sahu & Doibale, 2013). 
The studies included in this analysis were conducted among reproductive age women at house hold level 
and health facility among women seeking care for other than gynecological problem. All the studies were 
observational epidemiological cross-sectional studies drawing sample population by random sampling method. 
The response of clients on gynecological morbidity varies by place where interview is conducted and the 
profession of the interviewer. Respondents complained many types of problem when they were interviewed in a 
health facility and by health workers.  
The proportion of women reporting symptoms were the higher when they were interviewed by physician at 
health facility than when they were interviewed by lay person at household level. This result strongly suggests 
that anticipation of treatment influences responses, either by overcoming silence or inviting exaggeration.  
The result of the prospective study also suggests that repeated interview may elicit greater reporting 
symptoms than a single interview. Such a trend may reflect the development of closer rapport between 
respondent and interviewer over successive round or improved proficiency on the part of interviews. Therefore, 
the results of cross-sectional studies did not compared with prospective studies. 
Addressing gynecological morbidity is a complex process as women either don’t consider it as a significant 
health problem or hesitate to talk on it. Even though, women with gynecological morbidity face serious social 
consequences in terms of marital disharmony, exclusion from social and religious life.  
Gynecological morbidity has a great impact on life of women, their child and family as well. Women with 
gynecological morbidity may be challenged with multifaceted health, psychological and social problem. 
According to WHO, reproductive ill health accounts for 36.6% of the total disease burden among women aged 
15 to 45 years at a global level. It result in 250 million years of reproductive life loss each year in worldwide and 
reduce the overall productivity of women as much as 20%. 
Majority of women do not seek health care until it becomes an emergency. Women were associated with 
causes of this morbidity with curse, evil eye, watch craft, excessive body heat, and sterilization. Some women 
accept the problem as normal health ill of women; as a result, they do not seek care. Certain untreated conditions 
can cause pregnancy related complications, congenital infections, infertility, chronic pain and significantly 
increase the risk of acquiring Pelvic Inflammatory Disease and HIV [41]. 
Gynecological morbidity was associated with illiteracy, ignorance, gender discrimination and poor social 
status, lack of decision making power and inability to afford seeking health care, parity, early mirage and age. 
Cultural sensitive prevention, care and treatment are needed to alleviate the burden of this problem. 
Educating and empowering women are the magic bullet to maximize women’s health and quality of life. In turn, 
healthy women contribute a lot for countries development. 
High levels heterogeneity exhibited within the studies and among groups of studies the (I2=98.02%-
99.20%, p=00). Egger’s regression test indicated evidence of publication bias for gynecological morbidity 
(p=0.004 for pelvic organ prolapse and p=0.03 for infertility). But, there was no evidence of publication bias for 
reproductive tract infection (p=0.40), menstrual disorder (p=14) and overall gynecological morbidity (p=23). 
Begg’s test indicated no evidence of publication bias of all types of gynecological morbidities. 
Studies included in this analysis were conducted in different setup, geographic location, among participants 
of different cultural background and economic difference with different methodology. This variation leads to 
heterogeneity of the studies. In addition to this, the bias may be introduced into each study. Some of the paper 
asked whether participants have problem at any time in the life, in the past 6 month, in the past 3 month and 
other asked whether they are currently experiencing it. Recall periods of more than 2-4 weeks for closed 
question, or few days for open-ended questions, they appear to introduce bias from under reporting and 
misclassification. 
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Measurement and definition variation also affect the results of the same studies. This problem is more 
observed on menstrual disorder variable. The common recorded types of menstrual disorder include volume 
(heavy, normal or light), regularity (irregular, regular or absent), frequency (frequent, normal or infrequent), and 
duration (prolonged, normal or shortened) of menstrual episodes. Each term could be interpreted differently 
across the globe. To avoid this confusion, the Federation of International Gynecological and Obstetrics (FIGO) 
introduced a new classification called the PALMCOEIN system of abnormal uterine bleeding (AUB). The basic 
system comprises four categories that are defined by visually objective structural criteria (PALM: Polyp, 
Adenomyosis, Leiomyoma, and Malignancy or Hyperplasia); five (COEIN: Coagulopathy, Ovulatory disorders, 
Endometrium, iatrogenic and not yet classified). 
 
Conclusion 
The polled prevalence of overall gynecological morbidity was 22%. This prevalence is not an over estimated 
prevalence instead it may be underestimated because of silence of women in reporting the problem due to 
cultural influences, ignorance and embarrassment to talk about the problem. This study showed tips of the ice-
berg of gynecological morbidities, and the magnitude of the problem is more than the reported one. From this 
prevalence, we can conclude that the effect of gynecological morbidity is high to hamper the productivity of 
reproductive age of women in the world particularly in developing regions. 
The common reported gynecological morbidities were reproductive tract infection and menstrual disorders. 
Theses might be more prevalent among reproductive age women than other. Pelvic organ prolapse is common 
among menopause women than reproductive age women. Heterogeneity was noted in this analysis for the studies 
were drawn all over the world with different back ground and methodology. The burden of gynecological 
morbidity was higher among economically and culturally disadvantageous women. 
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